Records and reported status
Mar 25, 2026 FDA drug enforcement
Lack of Assurance of Sterility
Class II Reported ongoing
Distribution: Nationwide within the United States
Official source for Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1... Nov 17, 2025 FDA drug enforcement
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
Class II Reported ongoing
Distribution: Natinowide in the USA
Official source for Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, ... Apr 18, 2025 FDA drug enforcement
cGMP Deviations
Class II Reported ongoing
Distribution: Nationwide in the US
Official source for Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharm... Aug 8, 2024 FDA drug enforcement
Failed Impurities/Degradation Specifications - at 18-month Stability testing
Class II Reported ongoing
Distribution: CA and NV
Official source for Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy... May 10, 2024 FDA drug enforcement
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Class II Reported ongoing
Distribution: Product distributed to CA, FL, OK, KS and CT
Official source for Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc.... Jun 26, 2023 FDA drug enforcement
Failed Stability Specifications
Class II Reported ongoing
Distribution: Nationwide within the United States
Official source for Tizanidine Hydrochloride Tablet 4mg, packaged in a) 20 count-bottles (NDC 68788-7781-2), b)30-cou... Mar 27, 2023 FDA drug enforcement
CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for Alprazolam Tab, USP 0.25mg, (CIV), 30-count bottle, Rx Only, Preferred Pharmaceuticals, Inc. Manu... Mar 27, 2023 FDA drug enforcement
CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for Alprazolam Tab, USP 0.5mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7595-3), b) 60-count... Mar 27, 2023 FDA drug enforcement
CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for Alprazolam Tab, USP 1mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7596-3), b) 60-count b... Mar 23, 2023 FDA drug enforcement
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II Reported ongoing
Distribution: USA Nationwide
Official source for Atorvastatin Calcium Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured: Accord Healthca... Mar 23, 2023 FDA drug enforcement
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II Reported ongoing
Distribution: USA Nationwide
Official source for Atorvastatin Calcium Tablets, USP, 20 mg, packaged in: a) 90-count bottle (NDC 68788-7631-9); b) ... Mar 23, 2023 FDA drug enforcement
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II Reported ongoing
Distribution: USA Nationwide
Official source for Clopidogrel Tablets USP, 75 mg, 90-count bottles, Rx only, Manufactured: Accord Healthcare, Inc.,... Mar 23, 2023 FDA drug enforcement
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II Reported ongoing
Distribution: USA Nationwide
Official source for Doxazosin Tablets, USP, 2 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., D... Mar 23, 2023 FDA drug enforcement
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II Reported ongoing
Distribution: USA Nationwide
Official source for Doxazosin Tablets, USP, 4 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., D... Mar 23, 2023 FDA drug enforcement
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II Reported ongoing
Distribution: USA Nationwide
Official source for Finasteride Tablets, USP, 5 mg, packaged in: a) 30-count bottles (NDC 68788-6976-3); b) 90-count ... Mar 23, 2023 FDA drug enforcement
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II Reported ongoing
Distribution: USA Nationwide
Official source for Glimepiride Tablets, USP, 2 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., ... Mar 23, 2023 FDA drug enforcement
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II Reported ongoing
Distribution: USA Nationwide
Official source for Montelukast Sodium Tablets, USP, 10 mg, packaged in: a) 30-count bottle (NDC 68788-9438-3); b) 60... Mar 23, 2023 FDA drug enforcement
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II Reported ongoing
Distribution: USA Nationwide
Official source for Rosuvastatin Tablets, USP, 10 mg, Packaged as: a) 30-count bottle (NDC 68788-7086-3); b) 90-count... Mar 23, 2023 FDA drug enforcement
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II Reported ongoing
Distribution: USA Nationwide
Official source for Rosuvastatin Tablets, USP, 5mg, 30-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., ... Mar 23, 2023 FDA drug enforcement
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II Reported ongoing
Distribution: USA Nationwide
Official source for Pravastatin Sodium Tablets, USP, 20 mg, 90-count bottle, Rx only, Manufactured for: Accord Health...
Reasons in these listed records Lack of Assurance of Sterility Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale. cGMP Deviations Failed Impurities/Degradation Specifications - at 18-month Stability testing These examples come from this result page and are not a ranking of every recall reason.
Checking Preferred Pharmaceuticals, Inc. Is there a recall on preferred pharmaceuticals, inc. right now? This archive contains 36 records, including 24 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product.
How do I check my package or product? Compare the product, firm and lot, date, model or serial identifiers with the notice. Use the label-check guide if you need help locating an identifier.
Does a matching name mean every item is included? A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall.
What if the search finds no matching record? This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. Check source coverage and the agency's current notices.
Where can I find older records? Use monthly archives or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page.